Uber's Growth Slows as It Diversifies Business Ahead of IPO
Uber's net losses widened to nearly $1 billion in its latest quarter as it invested in new businesses prior to its initial public offering expected next year, the private company said in its self-reported financial disclosures.
The losses were 32 percent greater than the previous quarter.
Revenues were nearly $3 billion, up 38 percent over the same period last year but a slower rate of growth from the prior quarter.
For the first time, Uber disclosed some numbers related to its fast-growing Uber Eats delivery service. That division accounted for $2.1 billion of $12.7 billion in gross bookings ー a 150 percent increase from the same quarter last year.
Uber's losses can be partially attributed to its increasingly diversified business model, in which ride-hailing is but one of the ways the company intends to make money in the future. In addition to Uber Eats, which is growing in emerging markets and will soon [cover](https://www.cnbc.com/2018/10/23/uber-plans-to-expand-food-delivery-to-70percent-of-the-us.html) 70 percent of the U.S. population, Uber has invested in new mobility offerings like e-scooters and bike shares.
Uber is on course for an initial public offering in 2019 that could value the company at as much as $120 billion.
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!